endogenous inhibitor of NO synthase, NG, NG-dimethylarginine (asymmetrical dimethylarginine, ADMA) [13] . In normal human, this inhibitor is secreted unchanged in the urine. In patients with CRF, however, in whom the ability of elimination by the kidneys is strongly reduced, circulating levels of ADMA rise sufficiently to inhibit nitric oxide synthesis. Another explanation is accumulation of endogenous inhibitors of cytokines. TNF-so-luble receptors, and antibodies to IL-1 and IL-6 were more prevalent in serum of patients with CRF, while the levels of these cytokines were not elevated or even reduced [14] [15] [16] . Similarly, the production of IL-1 re-©1995 S.KargerAG, Basel 0028-2766/95/ 0692-0172$8.00/0 ceptor antagonist by unstimulated and stimulated peripheral mononuclear cells was directly correlated with renal function, while the production of IL-1 by these cells was reduced in patients with CRF [17] . The protective effect of CRF may be dependent on the balance between cytokines on the one hand and naturally occurring cytokine-spe-cific inhibitors or antagonists on the other hand. In patients with Lyme arthritis, for instance, the balance between IL-lß and IL-1 receptor antagonist in the synovial fluid is associated with the time of resolution of an attack of the disease [18] . Taken together, it is conceivable that the higher serum concentrations of antibodies to lipid-A, endogenous inhibitors of cytokines and NO synthesis in CRF patients might contribute to the reduction of cadiovascular failure and other organ system failures, and consequently the relatively fair prognosis in patients with prior CRF. More studies, however, are needed to unravel the precise role of these cytokine-specific inhibitors and inhibitors of NO synthesis in influencing the course of inflammation and sepsis. Since the outcome in patients with ARF has not improved despite major advances in hemopurification techniques and supportive therapy over the past decades, and prognosis in ARF is likely to be dependent on other organ system failures other than the kidneys [19] , future research should perhaps focus on the possible therapeutic effects of natural inhibitors of cytokines or NO synthesis.
